TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 141 filers reported holding TG THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,972,127 | -16.0% | 504,829 | -58.0% | 0.31% | -25.1% |
| Q3 2022 | $7,109,000 | +75.9% | 1,200,813 | +26.3% | 0.41% | +74.9% |
| Q2 2022 | $4,041,000 | +29.5% | 950,813 | +189.7% | 0.24% | +132.7% |
| Q1 2022 | $3,121,000 | +160.5% | 328,187 | +1325.1% | 0.10% | +129.5% |
| Q4 2020 | $1,198,000 | -56.5% | 23,029 | -83.7% | 0.04% | -83.4% |
| Q2 2020 | $2,754,000 | +56.4% | 141,364 | -21.0% | 0.26% | +26.8% |
| Q1 2020 | $1,761,000 | -42.9% | 178,964 | -35.5% | 0.21% | -22.9% |
| Q4 2019 | $3,082,000 | +54.7% | 277,639 | -21.7% | 0.27% | -20.3% |
| Q3 2019 | $1,992,000 | -35.1% | 354,719 | 0.0% | 0.34% | -27.0% |
| Q2 2019 | $3,068,000 | +490.0% | 354,719 | +448.1% | 0.47% | +529.7% |
| Q1 2019 | $520,000 | -21.0% | 64,719 | +29.4% | 0.07% | -72.0% |
| Q2 2018 | $658,000 | -7.3% | 50,000 | 0.0% | 0.26% | -37.0% |
| Q1 2018 | $710,000 | – | 50,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
| Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
| SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
| Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
| Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
| Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
| Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
| COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |